Tahla Munir, Keri Yang, Sheng Xu, Rhys Williams, Mazyar Shadman. "Comparative efficacy of zanubrutinib (ZANU) versus fixed-duration acalabrutinib plus venetoclax (AV) for first-line treatment of chronic lymphocytic leukemia (CLL): A matching-adjusted indirect comparison (MAIC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e19032